Ignite Creation Date:
2024-05-06 @ 3:17 AM
Last Modification Date:
2024-10-26 @ 11:31 AM
Study NCT ID:
NCT02259114
Status:
COMPLETED
Last Update Posted:
2021-01-26
First Post:
2014-10-03
Brief Title:
A Dose-Finding Study of Birabresib MK-8628 a Small Molecule Inhibitor of the Bromodomain and Extra-Terminal BET Proteins in Adults With Selected Advanced Solid Tumors MK-8628-003
Sponsor:
Oncoethix GmbH a subsidiary of Merck Co Inc Rahway New Jersey USA
Organization:
Oncoethix GmbH a subsidiary of Merck Co Inc Rahway New Jersey USA
Organization Data
Organization:
Oncoethix GmbH a subsidiary of Merck Co Inc Rahway New Jersey USA
Class:
INDUSTRY
Study ID:
8628-003
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Oncoethix GmbH a subsidiary of Merck Co Inc Rahway New Jersey USA
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None